We previously demonstrated that three weeks-FRD fed rats developed changes in liver glucose and lipid metabolism paralleling endocrine dysfunction (hyperinsulinemia, hyperleptinemia, higher plasminogen activator inhibitor-1 and lower adiponectin levels) and an insulin resistant state [14,15,16,17,18,19,20]. The gene discussed is SERPINE1; the disease is hyperinsulinism.